Navigation Links
APCER Pharma Sponsors Major Industry Conference
Date:6/21/2012

Princeton, NJ (PRWEB) June 21, 2012

APCER Pharma Solutions, Inc., the truly global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations, announced today that it is sponsoring and exhibiting at the 48th Annual Meeting of the Drug Information Association (DIA). The meeting takes place at the Philadelphia Convention Center, June 24-28, 2012, and is expected to draw more than 7,000 professionals from the pharmaceutical, biotechnology, and medical device industries.

“We have been exhibiting at the DIA Annual Meeting since our founding, and it has provided an informal platform for our global safety experts to communicate with the industry professionals that bear the responsibility for regulatory compliance for their companies,” said Suneet Walia, President and CEO of APCER Pharma. “We are pleased to be able to support the meeting even further this year through sponsorship of the DIA Welcome Reception.”

DIA is a neutral, global, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Its Annual Meeting features more than 270 sessions presented by top experts across government, industry, academia, and patient groups, along with exhibitors from contract research organizations, technology providers, research centers, and academia. APCER Pharma will have representatives from its offices in North America, Europe, and Asia available at Booth #2736 to share information regarding developments in global safety regulations and client engagement models that drive quality and compliance.

About APCER Pharma Solutions
APCER Pharma is a global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations. Its international team of highly experienced healthcare professionals, scientists, and technologists provides pharmaceutical, biotechnology, medical device, and consumer product companies with deep knowledge of worldwide regulations and best practices to comply with them. For more information on APCER Pharma Solutions, please call (+1) 609-455-1600, or visit the company website at http://www.apcerpharma.com.

Read the full story at http://www.prweb.com/releases/pharmacovigilance/apcerpharma/prweb9626562.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
2. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
3. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
5. aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
6. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
7. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
8. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
9. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Genesis Biopharma Issues Letter To Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
Breaking Biology News(10 mins):